- This event has passed.
2026 U.S.-Japan Healthcare Connection Reverse Pitch Event
Come hear pitches from leading Japan-focused strategic investors and pharmaceutical companies including AN Ventures, Astellas, Chugai Pharmaceuticals, Daiichi Sankyo, Nippon Life, Ono Pharmaceuticals and Recor Medical. Our presenters will share their investment and partnering priorities with the audience, and tell you how to connect with them to discuss strategic partnering opportunities.
This is an amazing opportunity to get in front of leading US biotech, pharma and life science strategic partners and investors that are that are interested in startup life science firms. In addition, we will have a panel discussion featuring market-entry experts from the life sciences industry who will share their thoughts on the topic “Why do therapeutics in Japan?”
This Biopharma-focused event is our sixth Reverse Pitch event – following on the heels of our successful Medtech and Diagnostics Reverse Pitch event in November 2025. The event will be followed by a networking reception where you will have the opportunity to connect with the presenters and others with deep experience in the Japanese market.
Hosted by:
